Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)
Conditions
- Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
Interventions
- BIOLOGICAL: filgrastim
- BIOLOGICAL: therapeutic autologous lymphocytes
- DRUG: cyclophosphamide
- OTHER: laboratory biomarker analysis
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators